Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: Serum Albumin in Acute Coronary Syndrome

View source ↗

Summary

A clinical trial is investigating serum albumin as a treatment for Acute Coronary Syndrome, sponsored by Sohag University; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Serum Albumin (human serum albumin)

Snippet

Sponsor: Sohag University | Conditions: Acute Coronary Syndrome | Status: NOT_YET_RECRUITING